Development and Implementation Model of Home Based Cardiac Rehabilitation With Family Empowerment Approach in Patient With ACS (HBCR in ACS)

The aim of this clinical trial is to determine whether home-based cardiac rehabilitation with a family empowerment approach can help acute coronary syndrome patients recover. The main questions to be answered are: \- Does home-based cardiac rehabilitation with a family approach effective in patients with acute coronary syndrome to improve health-related quality of life and peak Vo2? Researchers will compare with usual care to see if home-based cardiac rehabilitation with a family approach is more effective for improving health-related quality of life and peak Vo2 in ACS patients. Patient inclusion criteria 1. Patients with acute coronary syndrome who had undergone hospitalization, with a minimum home care time of 3 months and a maximum of 1 year, calculated from the day of discharge from the hospital until the time of the interview. 2. Aged 18-65 years old, participants were selected with age variations representing young adults, adults and the elderly. 3. Patients with first experience of SCA, participants were selected whether they had undergone PCI or not. 4. Patients living with family and family involved in the patient care process. 5. Physical condition allows for interviews. physical condition is evidenced by examination of stable vital signs (diastolic BP \>90, systolic \<150 mmhg; N: 60-100x/min; S: 36-380c, no pain). Psychological condition does not show symptoms of depression as measured by the Patient Health Questionnaire-9 instrument. 6. Willing to participate in the study. Participants will: For 12 weeks 1. Perform walking exercises as prescribed 2. Implement diets and stress management according to the module 3. Quit smoking 4. Medication compliance 5. visit the clinic to see a cardiologist, undergo a 6-minute walk test

NCT Number	NCT06625463
Lead Sponsor	Gadjah Mada University
Conditions	Home Based Rehabilitation, Acute Coronary Syndromes
Enrollment	90 participants
Start Date	2025-01-01
Primary Completion	2025-06-10 (estimated)
Study Completion	2025-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-06-15